Regeneron Pharmaceuticals
REGN
#130
Rank
$118.98 B
Marketcap
$1,080
Share price
-1.39%
Change (1 day)
49.64%
Change (1 year)

Regeneron Pharmaceuticals (REGN) - Total liabilities

Total liabilities on the balance sheet as of March 2024 : $7.37 B

According to Regeneron Pharmaceuticals's latest financial reports the company's total liabilities are $7.37 B. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Regeneron Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31$7.10 B8.5%
2022-12-31$6.55 B-1.73%
2021-12-31$6.66 B8.6%
2020-12-31$6.13 B65.2%
2019-12-31$3.71 B24.8%
2018-12-31$2.97 B13.62%
2017-12-31$2.62 B3.8%
2016-12-31$2.52 B29.16%
2015-12-31$1.95 B51.8%
2014-12-31$1.28 B28.88%
2013-12-31$0.99 B19.62%
2012-12-31$0.83 B-0.33%
2011-12-31$0.83 B49.19%
2010-12-31$0.56 B63.05%
2009-12-31$0.34 B13.79%
2008-12-31$0.30 B-36.41%
2007-12-31$0.47 B29.18%
2006-12-31$0.36 B19.05%
2005-12-31$0.30 B6.52%
2004-12-31$0.29 B-15.02%
2003-12-31$0.34 B39.22%
2002-12-31$0.24 B7.23%
2001-12-31$0.22 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
$87.95 B 1,092.09%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.04 B-45.20%๐Ÿ‡บ๐Ÿ‡ธ USA
$11.35 B 53.89%๐Ÿ‡บ๐Ÿ‡ธ USA
$101.94 B 1,281.66%๐Ÿ‡บ๐Ÿ‡ธ USA
$54.57 B 639.69%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$57.61 B 680.82%๐Ÿ‡ซ๐Ÿ‡ท France